Tuesday, September 21, 2021 1:35:20 AM
Penny World,
I really don't believe FDA will make a decision this month. Phyzer has developed a vaccine for children. FDA will concentrate on the vaccines instead of therapeutics. I'm thinking that it'll be November or December before FDA approval! Then it'll be well into 2022 before drug approval for market. It'll be almost 2 years by then since clinical trial approval for covid virus! It's sad to know how many patients could have been saved with aviptadil this year alone!.....
I really don't believe FDA will make a decision this month. Phyzer has developed a vaccine for children. FDA will concentrate on the vaccines instead of therapeutics. I'm thinking that it'll be November or December before FDA approval! Then it'll be well into 2022 before drug approval for market. It'll be almost 2 years by then since clinical trial approval for covid virus! It's sad to know how many patients could have been saved with aviptadil this year alone!.....
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
